Login to Your Account

Ramius Seeks Hostile Buyout of Cypress Bioscience at $4/Share

By Catherine Hollingsworth

Tuesday, July 20, 2010
Activist shareholder Ramius Value and Opportunity Advisors LLC said that it is seeking to take over Cypress Bioscience Inc., offering to buy the rest of the company shares that it does not already own for $4 per share. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription